查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1991384

2026-2034年全球外泌體市場規模、佔有率、趨勢和成長分析報告

Global Exosomes Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 169 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計外泌體市場將從 2025 年的 5.9 億美元成長到 2034 年的 63.8 億美元，2026 年至 2034 年的複合年成長率為 30.37%。

由於細胞生物學和再生醫學研究的進展，全球外泌體市場正經歷顯著成長。外泌體是細胞釋放的微小細胞外囊泡，在細胞間通訊和分子運輸中發揮至關重要的作用。科學家正在探索其在診斷、藥物傳遞和治療方面的潛在應用，尤其是在腫瘤學和再生醫學領域。

多種因素正在推動外泌體市場的擴張。生物醫學研究投入的增加以及人們對個人化醫療日益成長的興趣，促使科學家探索外泌體的治療潛力。由於外泌體能夠遞送蛋白質和RNA等生物分子，它們正成為疾病檢測和標靶治療的重要工具。

隨著研究的深入和臨床應用的發展，外泌體市場預計未來將持續成長。分離和表徵技術的進步有望促進外泌體在醫學研究和治療方法開發中的應用。隨著生物技術和生命科學產業的不斷創新，外泌體將成為下一代治療策略的關鍵組成部分。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球外泌體市場：依產品與服務分類

  • 市場分析、洞察與預測
  • 試劑盒和試劑
  • 抗體
  • 用於分離、純化和定量分析的試劑盒和試劑。
  • 其他試劑盒和試劑
  • 裝置
  • 服務

第5章 全球外泌體市場：依應用分類

  • 市場分析、洞察與預測
  • 診斷
  • 治療

第6章：全球外泌體市場：依適應症分類

  • 市場分析、洞察與預測
  • 癌症
  • 神經退化性疾病
  • 心血管疾病
  • 感染疾病
  • 其他跡象

第7章 全球外泌體市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 製藥和生物技術公司
  • 醫院和診斷中心
  • 學術研究機構

第8章 全球外泌體市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • Bio-Techne Corp
    • QIAGEN
    • Beckam Coulter（Danaher Corp）
    • Diagenode（Hologic Inc）
    • Lonza
    • Abcam
    • RoosterBio Inc
    • Miltenyi Biotech
    • Fujifilm Holdings Corp
    • Hitachi Chemical Diagnostics Inc
    • Clara Biotech
簡介目錄
Product Code: VMR11213631

The Exosomes Market size is expected to reach USD 6.38 Billion in 2034 from USD 0.59 Billion (2025) growing at a CAGR of 30.37% during 2026-2034.

The global exosomes market has experienced significant growth due to increasing research in cell biology and regenerative medicine. Exosomes are tiny extracellular vesicles released by cells that play an important role in cell communication and molecular transport. Scientists are exploring their potential applications in diagnostics, drug delivery, and therapeutic treatments, particularly in oncology and regenerative medicine.

Several drivers are supporting the expansion of the exosomes market. Growing investment in biomedical research and increasing interest in personalized medicine have encouraged scientists to study the therapeutic potential of exosomes. Their ability to carry biological molecules such as proteins and RNA makes them valuable tools in disease detection and targeted therapies.

Looking ahead, the exosomes market is expected to expand as research advances and clinical applications develop. Improvements in isolation and characterization technologies may enhance the use of exosomes in medical research and treatment development. As biotechnology and life sciences industries continue to innovate, exosomes are likely to become an important component of next-generation therapeutic strategies.

MARKET SEGMENTATION

By Products & Services

  • Kits & Reagents
  • Antibodies
  • Isolation, Purification, Quantitation Kits & Reagents
  • Other Kits & Reagents
  • Instruments
  • Services

By Application

  • Diagnostic
  • Therapeutic

By Indication

  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Other Indications

By End-Users

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, BioTechne Corp, QIAGEN, Beckam Coulter Danaher Corp, Diagenode Hologic Inc, Lonza, Abcam, RoosterBio Inc, Miltenyi Biotech, Fujifilm Holdings Corp, Hitachi Chemical Diagnostics Inc, Clara Biotech
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXOSOMES MARKET: BY PRODUCTS & SERVICES 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Products & Services
  • 4.2. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Isolation, Purification, Quantitation Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Other Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EXOSOMES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Diagnostic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Therapeutic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EXOSOMES MARKET: BY INDICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Indication
  • 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Neurodegenerative Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EXOSOMES MARKET: BY END-USERS 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-users
  • 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Hospitals & Diagnostics Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EXOSOMES MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Products & Services
    • 8.2.2 By Application
    • 8.2.3 By Indication
    • 8.2.4 By End-users
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Products & Services
    • 8.3.2 By Application
    • 8.3.3 By Indication
    • 8.3.4 By End-users
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Products & Services
    • 8.4.2 By Application
    • 8.4.3 By Indication
    • 8.4.4 By End-users
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Products & Services
    • 8.5.2 By Application
    • 8.5.3 By Indication
    • 8.5.4 By End-users
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Products & Services
    • 8.6.2 By Application
    • 8.6.3 By Indication
    • 8.6.4 By End-users
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EXOSOMES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Thermo Fisher Scientific Inc
    • 10.2.2 Bio-Techne Corp
    • 10.2.3 QIAGEN
    • 10.2.4 Beckam Coulter (Danaher Corp)
    • 10.2.5 Diagenode (Hologic Inc)
    • 10.2.6 Lonza
    • 10.2.7 Abcam
    • 10.2.8 RoosterBio Inc
    • 10.2.9 Miltenyi Biotech
    • 10.2.10 Fujifilm Holdings Corp
    • 10.2.11 Hitachi Chemical Diagnostics Inc
    • 10.2.12 Clara Biotech